Kelly Thompson is an NHMRC Emerging Leader working with the Global Women’s Health program and Critical Care Division at The George Institute for Global Health.
Kelly’s doctorate evaluated the epidemiology, economics, and long-term outcomes of patients treated for sepsis in Australian intensive care units. Her focus was primarily on understanding the cost-effectiveness and sex-related treatment differences of corticosteroid therapy for critically ill patients with septic shock. Her research found sex differences in both the cost-effectiveness of treatment, where corticosteroid therapy was more cost-effective in women compared to men and in clinical outcomes, where men were found to have some improved clinical outcomes, compared to women.
Since 2018, Kelly has spearheaded the establishment of The George Institute’s, Global Women’s Health Program, taking responsibility for building research strategy and teams across the Institute’s offices in Australia, China, India, and the UK.
She is an honorary research fellow with The Australian Sepsis Network and a member of the Taskforce on Women and NCDs.
Kelly is passionate about achieving health equity for underserved populations globally, particularly women and girls. Improving health equity in sepsis is the focus of her NHMRC postdoctoral fellowship.